Search results
FDA panel recommends new COVID-19 vaccine formula for fall
UPI· 1 day agovaccine makers to focus on the latest versions of the virus, and not the JN.1 variant. A U.S. Food...
Excess deaths remained elevated even after COVID-19 vaccines, study finds
The Center Square· 3 days agoThe study, published in BMJ Public Health, found more research is needed to determine why more...
Moderna Seeks FDA Approval For Updated COVID-19 Shot For Upcoming Season
Benzinga· 3 hours agoThe submission is based on FDA guidance, which advised that COVID-19 vaccines should be updated to a...
A New COVID Booster Targeting JN.1 May Arrive This Fall
Verywell Health via Yahoo News· 3 hours agoAn FDA panel voted to recommend an updated COVID-19 vaccine targeting the JN.1 variant. Here's what...
Moderna Files FDA Application for the JN.1 Targeting COVID-19 Vaccine
The Kansas City Star· 6 hours agoManufacturing is underway and doses of Moderna’s Spikevax 2024-2025 formula will be ready to ship as early as August, pending regulatory approval
FDA panel recommends new COVID-19 vaccine formula for fall
United Press International via Yahoo News· 1 day agoA U.S. Food and Drug Administration advisory panel on Wednesday recommended updating the formula for...
FDA vaccine advisers vote unanimously in favor of updated Covid-19 shot for fall
KITV Honolulu· 2 days agoThe committee voted on the question, “For the 2024-2025 Formula of COVID-19 vaccines in the U.S.,...
FDA Advisors Give a Hearty Thumbs Up to a COVID Vaccine Based on the JN.1 Strain
MedPage Today· 3 days agoAn FDA advisory committee voted unanimously, 16-0, Wednesday to recommend that the COVID-19 vaccines...
FDA advisers urge targeting JN.1 strain in recipe for fall's COVID vaccines
San Francisco Chronicle· 2 days agoGovernment advisers Wednesday said it’s time to update the recipe for the COVID-19 vaccines...
The new technology inside COVID-19 vaccines— mRNA
KRGV Rio Grande Valley· 5 days agoWhen you think of vaccines, you may think about traditional vaccines with weak or inactive parts of a virus to trigger an immune response. Today...